퇴행성 요추 디스크 질환시장 : 산업 규모, 점유율, 동향, 기회, 예측, 치료 유형별, 투여 경로별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By Route of administration, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,401,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,824,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,380,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

퇴행성 요추 디스크 질환 세계 시장 규모는 2024년 90억 6,000만 달러로 평가되었고, 예측 기간 동안 134억 5,000만 달러에 이르고, 2030년까지 6.78%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

퇴행성 요추 디스크 질환(DDD) 세계 시장은 몇 가지 중요한 요인으로 인해 크게 성장하고 변화하고 있습니다. 요추 DDD는 허리의 추간판이 점차적으로 퇴행하여 만성 통증, 운동 능력 저하, 삶의 질 저하로 이어지는 특징적인 퇴행성 질환으로, 확산되고 쇠약해지는 질환입니다. 세계 인구의 고령화와 좌식 생활이 증가함에 따라 요추 DDD의 유병률은 증가 추세에 있으며, 진단, 치료 및 수술적 개입에 대한 큰 시장이 형성되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	90억 6,000만 달러
시장 규모 : 2030년	134억 5,000만 달러
CAGR : 2025-2030년	6.78%
급성장 부문	병원 및 클리닉
최대 시장	북미

시장 성장 촉진요인

인구 고령화

주요 시장 이슈

치료비 폭등

주요 시장 동향

수술 기술의 발전

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 치료 유형별(약물 치료, 생물학적 제제, 기타)
  • 투여 경로별(경구, 주사, 기타)
  • 최종사용자별(병원 및 진료소, 외래 진료 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵
  • 치료 유형별
  • 투여 경로별
  • 최종사용자별
  • 지역별

제5장 아시아태평양의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율과 예측
  • 치료 유형별
  • 투여 경로별
  • 최종사용자별
  • 국가별
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 호주
  • 일본
  • 한국

제6장 유럽의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 스페인
  • 이탈리아
  • 영국

제7장 북미의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제8장 남미의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제9장 중동 및 아프리카의 퇴행성 요추 디스크 질환시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)

제10장 시장 역학

• 성장 촉진요인
• 과제

제11장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 인수합병(M&A)

제12장 세계의 퇴행성 요추 디스크 질환시장 : SWOT 분석

제13장 Porter의 Five Forces 분석

• 업계내 경쟁
• 신규 참여 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Sorrento Therapeutics
• Spine Thera
• Eliem Therapeutics
• Scilex Holding
• Sinfonia Biotherapeutics
• Seikagaku Corporation
• Kolon life Science
• Vita Sciences
• Aurobindo Pharma
• Le Neurotech

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH

영문 목차

영문목차

Global Lumbar Degenerative Disc Disease Market was valued at USD 9.06 Billion in 2024 and is expected to reach USD 13.45 Billion in the forecast period with a CAGR of 6.78% through 2030. The global market for Lumbar Degenerative Disc Disease (DDD) is experiencing significant growth and transformation due to several key factors. Lumbar DDD is a prevalent and debilitating condition characterized by the gradual degeneration of intervertebral discs in the lower back, leading to chronic pain, reduced mobility, and decreased quality of life. As the world's population continues to age and lifestyles become increasingly sedentary, the prevalence of Lumbar DDD is on the rise, creating a substantial market for diagnostic, therapeutic, and surgical interventions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 9.06 Billion
Market Size 2030	USD 13.45 Billion
CAGR 2025-2030	6.78%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America

Key Market Drivers

Aging Population

The aging population is a significant driver behind the growth of the Global Lumbar Degenerative Disc Disease (DDD) Market. Lumbar DDD, characterized by the gradual deterioration of intervertebral discs in the lower back, becomes increasingly prevalent with age. As the global demographic shifts toward older age groups, the incidence of Lumbar DDD is rising. For instance, in the United States, the population aged 65 and over grew from 40.3 million in 2010 to 55.8 million in 2020, a 38.6% increase, accounting for 16.8% of the total population. This trend is particularly prominent in developed countries where life expectancy has increased due to advancements in healthcare and living standards.

As individuals age, natural wear and tear on spinal discs become more pronounced, increasing susceptibility to Lumbar DDD. Studies have shown that one-third of people aged 40-59 have evidence of degenerative disc disease. This age-related degeneration can lead to chronic back pain, reduced mobility, and diminished quality of life. Consequently, there is a growing demand for medical interventions and treatments to address the symptoms and complications associated with Lumbar DDD among the elderly. Healthcare providers are witnessing a surge in older patients seeking diagnosis and treatment for Lumbar DDD, leading to increased awareness and the development of innovative therapies tailored to aging individuals. Additionally, older patients are more likely to undergo surgical procedures to manage severe cases of Lumbar DDD, further fueling the market's growth in surgical techniques and implantable devices.

Key Market Challenges

High Cost of Treatment

The cost of treating Lumbar DDD can be substantial, often encompassing a range of expenses, including diagnostic tests, physician consultations, physical therapy, medications, and, in some cases, surgical procedures. For many patients, especially those without comprehensive health insurance coverage, these costs can lead to a substantial financial burden. The prospect of high out-of-pocket expenses can deter individuals from seeking medical attention promptly, leading to delayed diagnosis and treatment. The high cost of treatment exacerbates healthcare disparities, making access to care unequal. Low-income individuals and those without adequate insurance coverage are particularly vulnerable. These disparities can result in unequal access to diagnostic tools, specialized consultations, and advanced treatments for Lumbar DDD. In essence, the cost barrier creates a divide in the quality of care received by patients, depending on their financial resources.

Delayed diagnosis and treatment due to financial concerns can have severe consequences for Lumbar DDD patients. This condition often worsens over time, leading to increased pain, reduced mobility, and a decreased quality of life. Delayed intervention can result in the progression of the disease to more severe stages, necessitating more extensive and costly treatments in the long run.

Key Market Trends

Advancements in Surgical Techniques

Advancements in surgical techniques have emerged as a pivotal factor propelling the growth of the Global Lumbar Degenerative Disc Disease (DDD) Market. Lumbar DDD, characterized by the deterioration of intervertebral discs in the lower back, can cause excruciating pain and severely compromise an individual's quality of life. However, recent strides in surgical approaches have revolutionized the field of Lumbar DDD treatment, offering patients safer, more effective, and less invasive options. Procedures such as spinal fusion and artificial disc replacement have seen remarkable advancements, making them increasingly attractive treatment choices. These surgical techniques have become safer, thanks to improved instrumentation and surgical tools that enhance precision and reduce the risk of complications. Surgeons now have access to innovative implants, including artificial discs and bone graft substitutes, which have significantly improved patient outcomes by replicating the natural biomechanics of the spine.

Moreover, the minimally invasive approach to Lumbar DDD surgery is gaining prominence. Minimally invasive surgery entails smaller incisions, reduced muscle disruption, and shorter recovery times compared to traditional open procedures. Techniques like endoscopic discectomy and laser-assisted surgery have made Lumbar DDD treatments more patient-friendly, as they minimize postoperative discomfort and hospital stays. Patients can often return to their daily activities more quickly, contributing to a higher quality of life.

Key Market Players

• Sorrento Therapeutics
• Spine Thera
• Eliem Therapeuticsa
• Scilex Holding
• Sinfonia Biotherapeutics
• Seikagaku Corporation
• Kolon life Science
• Vita Sciences
• Aurobindo Pharma
• Le Neurotech

Report Scope:

In this report, the Global Lumbar Degenerative Disc Disease Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lumbar Degenerative Disc Disease Market, By Treatment Type:

• Drug Treatment
• Biologics
• Other

Lumbar Degenerative Disc Disease Market, By Route of administration:

• Oral
• Injectables
• Other

Lumbar Degenerative Disc Disease Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Lumbar Degenerative Disc Disease Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lumbar Degenerative Disc Disease Market.

Available Customizations:

Global Lumbar Degenerative Disc Disease market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Lumbar Degenerative Disc Disease Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Treatment Type (Drug Treatment, Biologics, Other)
  • 4.2.2. By Route of administration (Oral, Injectables, Other)
  • 4.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Treatment Type
  • 4.3.2. By Route of administration
  • 4.3.3. By End User
  • 4.3.4. By Region

5. Asia Pacific Lumbar Degenerative Disc Disease Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type
  • 5.2.2. By Route of administration
  • 5.2.3. By End User
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Treatment Type
      • 5.3.1.2.2. By Route of administration
      • 5.3.1.2.3. By End User
  • 5.3.2. India Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Treatment Type
      • 5.3.2.2.2. By Route of administration
      • 5.3.2.2.3. By End User
  • 5.3.3. Australia Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Treatment Type
      • 5.3.3.2.2. By Route of administration
      • 5.3.3.2.3. By End User
  • 5.3.4. Japan Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Treatment Type
      • 5.3.4.2.2. By Route of administration
      • 5.3.4.2.3. By End User
  • 5.3.5. South Korea Lumbar Degenerative Disc Disease Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Treatment Type
      • 5.3.5.2.2. By Route of administration
      • 5.3.5.2.3. By End User

6. Europe Lumbar Degenerative Disc Disease Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type
  • 6.2.2. By Route of administration
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
      • 6.3.1.2.2. By Route of administration
      • 6.3.1.2.3. By End User
  • 6.3.2. Germany Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
      • 6.3.2.2.2. By Route of administration
      • 6.3.2.2.3. By End User
  • 6.3.3. Spain Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type
      • 6.3.3.2.2. By Route of administration
      • 6.3.3.2.3. By End User
  • 6.3.4. Italy Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Treatment Type
      • 6.3.4.2.2. By Route of administration
      • 6.3.4.2.3. By End User
  • 6.3.5. United Kingdom Lumbar Degenerative Disc Disease Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Treatment Type
      • 6.3.5.2.2. By Route of administration
      • 6.3.5.2.3. By End User

7. North America Lumbar Degenerative Disc Disease Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type
  • 7.2.2. By Route of administration
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
      • 7.3.1.2.2. By Route of administration
      • 7.3.1.2.3. By End User
  • 7.3.2. Mexico Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
      • 7.3.2.2.2. By Route of administration
      • 7.3.2.2.3. By End User
  • 7.3.3. Canada Lumbar Degenerative Disc Disease Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
      • 7.3.3.2.2. By Route of administration
      • 7.3.3.2.3. By End User

8. South America Lumbar Degenerative Disc Disease Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type
  • 8.2.2. By Route of administration
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
      • 8.3.1.2.2. By Route of administration
      • 8.3.1.2.3. By End User
  • 8.3.2. Argentina Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
      • 8.3.2.2.2. By Route of administration
      • 8.3.2.2.3. By End User
  • 8.3.3. Colombia Lumbar Degenerative Disc Disease Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
      • 8.3.3.2.2. By Route of administration
      • 8.3.3.2.3. By End User

9. Middle East and Africa Lumbar Degenerative Disc Disease Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type
  • 9.2.2. By Route of administration
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
      • 9.3.1.2.2. By Route of administration
      • 9.3.1.2.3. By End User
  • 9.3.2. Saudi Arabia Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
      • 9.3.2.2.2. By Route of administration
      • 9.3.2.2.3. By End User
  • 9.3.3. UAE Lumbar Degenerative Disc Disease Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type
      • 9.3.3.2.2. By Route of administration
      • 9.3.3.2.3. By End User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Lumbar Degenerative Disc Disease Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Sorrento Therapeutics
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Spine Thera
• 14.3. Eliem Therapeutics
• 14.4. Scilex Holding
• 14.5. Sinfonia Biotherapeutics
• 14.6. Seikagaku Corporation
• 14.7. Kolon life Science
• 14.8. Vita Sciences
• 14.9. Aurobindo Pharma
• 14.10. Le Neurotech

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료